Top 10 Companies in Bioinformatics Market

The Bioinformatics Market is expected to grow at a CAGR of 13.3% from 2023 to 2030 to reach $27.98 billion by 2030, according to Meticulous Research^®. The bioinformatics market includes knowledge management software, bioinformatics platforms, and services. The growth of the bioinformatics market is driven by the growth of the biotech and pharmaceutical industries, initiatives supporting genomics research, and the rising need to develop novel drugs/drug molecules. Untapped markets in emerging economies, growing clinical applications of genomic technologies, and the increasing use of bioinformatics in agriculture are expected to generate growth opportunities for the stakeholders in this market.

Here are the top 10 companies operating in the Bioinformatics Market

Thermo Fisher Scientific Inc. (U.S.)

Founded in 1956 and headquartered in Massachusetts, U.S., Thermo Fisher offers products and services in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, government, and academic sectors. The company operates through four business segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions and Analytical Instruments business segments offer bioinformatics software and services such as data analysis using Torrent Suite Software and Next-Generation Sequencing Bioinformatics Training.

The company has a direct presence through its regional offices and production sites in the U.S., Mexico, Brazil, Germany, Belgium, Austria, the U.K., Italy, the Netherlands, South Africa, the UAE, India, China, Japan, Australia, and the Republic of Korea through its subsidiaries, R&D sites, and a strong distribution network. Some of its major subsidiaries are Molecular Probes, Inc. (U.S.), Thermo Electron North America LLC (U.S.), European Laboratory Holdings Limited (U.K.), and Patheon France SAS (France).

Eurofins Genomics LLC (Germany) (Subsidiary of Eurofins Scientific SE)

Founded in 1990 and headquartered in Bavaria, Germany, Eurofins Genomics LLC provides services for gene synthesis, DNA sequencing, clinical diagnostic testing, and bio-analytical services for industrial and academic research. The company provides De Novo Assembly services, mapping and variance analysis, transcriptome analysis, amplicon variance analysis, and mad BLAST sequence analysis services in the bioinformatics market.

Eurofins Genomics has a presence in 54 countries through its subsidiaries and laboratories. The company has around 900 laboratories offering bioinformatics services. Some of the major subsidiaries of the company operating in the bioinformatics market are Eurofins Genomics AT GmbH (Austria), Eurofins Genomics A/S (Denmark), Eurofins Genomics SAS (France), and Eurofins Genomics GmbH (Germany), among others.

Revvity, Inc. (U.S.)

Founded in 2023 and headquartered in Massachusetts, U.S., Revvity, Inc. (U.S.) is a multinational company that offers products, solutions, and services for the life sciences and diagnostics markets. The company operates through two reportable business segments: Discovery & Analytical Solutions and Diagnostics. Bioinformatics solutions are offered through both these segments.

The company’s manufacturing and R&D facilities are in several countries, including the U.S., China, Japan, and Germany. Furthermore, the company has a strong network of sales and marketing channels and service personnel in over 38 countries and sells its products and services in over 190 countries.

 Agilient Technologies, Inc. (U.S.)

Founded in 1999 and headquartered in California, U.S., Agilent Technologies provides application-focused solutions to the life sciences, diagnostics, and applied chemical markets. The company operates through three business segments: Life Sciences and Applied Markets; Agilent CrossLab; and Diagnostics and Genomics. The company operates in the bioinformatics market through two of its business segments, namely, Life Sciences and Applied Markets and Diagnostics and Genomics.

Agilent has a presence across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa and customers in over 110 countries through its subsidiaries and a strong distribution network. The company has research & development and manufacturing sites in California, Colorado, Delaware, Massachusetts, Texas, Vermont, Washington, Australia, China, Denmark, Germany, Italy, Japan, Malaysia, Singapore, and the U.K.

 Illumina, Inc. (U.S.)

Founded in 1998 and headquartered in California, U.S., Illumina is a provider of sequencing- and array-based solutions for genomic and genetic analysis. The company operates through two reportable segments: Core Illumina and GRAIL. The Core Illumina segment offers bioinformatics solutions to simplify workflows and accelerate analysis.

Illumina provides its solutions to government laboratories, genomic research centers, academic institutions, hospitals, commercial molecular diagnostics laboratories, and pharmaceutical and consumer genomics companies. The company has manufacturing sites and laboratories in the U.S., Singapore, and the U.K.

Illumina distributes its products in North America, Europe, Latin America, Asia-Pacific, and the Middle East & Africa through its distributors. Some of its major subsidiaries are Illumina GmbH (Germany), Illumina Australia Pty. Ltd. (Australia), Illumina UK, Ltd. (U.K.), Illumina Italy S.r.l. (Italy), Illumina Netherlands B.V. (Netherlands), and Illumina K.K. Japan (Japan).

Meticulous Research in its latest publication on Bioinformatics Market has predicted the growth of 13.3% during the forecast year 2023-2030.

 
Qiagen N.V. (Netherlands)

Founded in 1984 and headquartered in Venlo, Netherlands, Qiagen N.V. is one of the leading providers of sample and assay technologies for molecular diagnostics, applied testing, and academic and pharmaceutical research. The company offers its products through only one reportable segment and provides them in two major markets: Molecular Diagnostics and Life Sciences.

Qiagen’s product offerings include diagnostics solutions, PCR products, genomic or NGS products, consumables, and instruments for sample technologies. Furthermore, the company offers more than 500 core products consisting of instruments, kits, bioinformatics solutions, and a wide range of NGS services, such as RNA sequencing services, DNA sequencing services, whole genome amplification services, and RNA isolation services.

The company has a global presence, marketing its products in over 130 countries. It operates facilities in multiple countries, including the U.S., China, Germany, Poland, the Philippines, Denmark, Romania, Spain, and the U.K. Sales are managed through distributors, sales subsidiaries, and direct sales to customers. Subsidiaries primarily handle sales in the Americas, Europe, Asia, and Australia.

 DNAnexus, Inc. (U.S.)

Founded in 2009 and headquartered in California, U.S., DNAnexus, Inc. provides scalable, secure, and intuitive biomedical data analysis, bioinformatics, and software for healthcare and life sciences applications. The company supports and manages more than 65 petabytes of complex multi-omic, genomic, and clinical datasets and provides informatics solutions for multi-omics data science exploration, discovery & analysis, next-generation sequencing data analysis, and customized private & collaborative portals.

The company offers its solutions to various end users, including biobanks, academic research institutions, clinical diagnostic laboratories, pharmaceutical companies, and government organizations. Its products are utilized by scientists in approximately 48 countries to gain insights into precision medicine, drive scientific discovery, and enhance patient care. Furthermore, the company’s offerings cater to nearly 100 enterprise customers across North America, Asia-Pacific, Europe, South America, and Africa.

Dassault Systems SE (France)

Founded in 1981 and headquartered in Vélizy-Villacoublay, Île-de-France, France, Dassault Systemes SE is a European software company that develops 3D design, 3D digital mock-up, and product lifecycle management (PLM) software. It is a 3D experience company that provides end-to-end software, content, and services designed to support companies’ innovation processes. The company conducts its business through three business segments, namely Manufacturing Industries, Life Sciences & Healthcare, and Infrastructures & Cities. The company operates in the bioinformatics market through its Life Sciences & Healthcare business segment.

Dassault Systemes SE has a diverse customer base, and the company provides its software solutions to various industries, such as aerospace & defense, transportation & mobility, marine & offshore, architecture, engineering & construction, consumer goods & retail, consumer packaged goods, life sciences, energy, and process & utilities.

Dassault Systemes SE has more than 182 offices in 42 countries across the globe. The company has a geographic presence in Europe, the Americas, and Asia. Medidata Solutions (U.S.) and BIOVIA (U.S.) are the subsidiaries of Dassault Systemes offering Bioinformatics solutions.

Azenta, Inc. (U.S.)

Founded in 1978 and headquartered in Massachusetts, U.S., Azenta, Inc. provides life sciences sample exploration and management solutions. The company operates through two business segments: Life Sciences Products and Life Sciences Services. Bioinformatics solutions are offered through both business segments.

The Life Sciences Products business segment includes sample management solutions, which include consumables and instruments for supporting workflows and informatics. Life Sciences Services business provides solutions in genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research and development markets.

The company has its major manufacturing facilities in Manchester and Wotton, the U.K., and Massachusetts, the U.S. The principal product service and support locations include Massachusetts, the U.S., and Manchester, the U.K. The company offers sample management storage and transportation services in the U.S., Germany, Canada, Singapore, and China. The sales and service centers are present in Asia, Europe, the Middle East, and North America. Some of the subsidiaries of the company include Azenta Germany GmbH (Germany), Azenta Japan Corp. (Japan), GENEWIZ France Ltd. (France), GENEWIZ UK Ltd. (U.K.), Azenta Life Sciences Canada, Inc. (Canada), and Azenta Singapore Pte Ltd. (Singapore).

 F. Hoffmann-La Roche (Switzerland)

Founded in 1896 and headquartered in Basel, Switzerland, F. Hoffmann-La Roche, commonly known as Roche, is a healthcare company that develops, manufactures, and markets a wide range of healthcare solutions. The company has two reportable business divisions, namely Pharmaceuticals and Diagnostics.

The Diagnostics division is further segmented into Core Lab, Molecular Lab, Point of Care, Diabetes Care, and Pathology Lab. The company offers bioinformatics solutions through the Diagnostics segment. Roche offers bioinformatics solutions through Navify and Cobas brands. The Diagnostics division is engaged in developing a wide range of diagnostic products and solutions such as in-vitro diagnostics solutions, molecular diagnostics, clinical chemistry & immunoassays, point-of-care testing, and digital health solutions.

Roche has a presence in the U.S., Germany, Switzerland, Japan, China, India, New Zealand, Australia, Latin America, and Africa. The company has 23 manufacturing sites and 29 research and development sites. Some of its subsidiaries are Roche Diagnostics (U.S.), Roche Diagnostics GmbH (Germany), Roche Diagnostics France SAS (France), Roche Diagnostics S.p.A. (Italy), Roche Diagnostics International AG (Switzerland), Roche Diagnostics Limited (U.K.), Roche Diagnostics (Shanghai) Ltd. (China), and Roche Diagnostics K.K (Japan).

Authoritative Research on the Bioinformatics Market – Global Opportunity Analysis and Industry Forecast (2023-2030)

Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following:

• Recent financial performance
• Key products
• Significant company strategies
• Partnerships and acquisitions

The Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.